The leading, authoritative journal for over 30 years, Biotechnology Law Report is devoted to the evolving body of law and government regulation concerning biotechnology, particularly in the industries in which new products from these technologies are developing the most rapidly: pharmaceuticals, chemicals, agriculture, food processing, energy, mineral recovery, and waste treatment. The Journal provides rapid reporting on all legal aspects, and reproduces critical, often hard-to-obtain documents. Biotechnology Law Report is highly recommended for law firms or corporate legal department library collections contributing research services to biotechnology research or a patent law practice.
Biotechnology Law Report coverage includes:
- Pharmaceutical regulatory affairs
- Agricultural and environmental regulatory affairs
- Patents and patent litigation
- Licensing and collaborations
- Financial and shareholder news
- Meeting Notices
Biotechnology Law Report is under the editorial leadership of Editor-in-Chief Gerry J. Elman, Elman Technology Law, P.C.; Executive Editor Christopher M. Holman, University of Missouri–Kansas City School of Law; and other leading investigators. View the entire editorial board.
Audience: Biotechnology patent officers, agricultural and environmental researchers and specialists, biotechnology lawyers, among others
The views, opinions, findings, conclusions and recommendations set forth in any
Journal article are solely those of the authors of those articles and do not necessarily
reflect the views, policy or position of the Journal, its Publisher, its editorial
staff or any affiliated Societies and should not be attributed to any of them.